Attitudes toward and training in medications for opioid use disorders: a descriptive analysis among employees in the youth legal system and community mental health centers.

IF 3 3区 医学 Q2 SUBSTANCE ABUSE Substance Abuse Treatment, Prevention, and Policy Pub Date : 2024-06-21 DOI:10.1186/s13011-024-00614-w
Lauren M O'Reilly, Katherine Schwartz, Steven A Brown, Allyson Dir, Logan Gillenwater, Zachary Adams, Tamika Zapolski, Leslie A Hulvershorn, Matthew Aalsma
{"title":"Attitudes toward and training in medications for opioid use disorders: a descriptive analysis among employees in the youth legal system and community mental health centers.","authors":"Lauren M O'Reilly, Katherine Schwartz, Steven A Brown, Allyson Dir, Logan Gillenwater, Zachary Adams, Tamika Zapolski, Leslie A Hulvershorn, Matthew Aalsma","doi":"10.1186/s13011-024-00614-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Research demonstrates gaps in medications for opioid use disorder uptake (MOUDs; methadone, buprenorphine, and naltrexone) especially among adolescents. These gaps may be partly attributable to attitudes about and training in MOUDs among youth-serving professionals. We extended prior research by conducting descriptive analyses of attitudes regarding effectiveness and acceptability of MOUDs, as well as training in MOUDs, among youth legal system (YLS) employees and community mental health center (CMHC) personnel who interface professionally with youth.</p><p><strong>Methods: </strong>Using survey data from participants (n = 181) recruited from eight Midwest counties, we examined: (1) differences in MOUD attitudes/training by MOUD type and (2) by respondent demographics, and (3) prediction of MOUD attitudes/training by participant-reported initiatives to implement evidence-based practices (EBPs), workplace culture around EBPs, and workplace stress. Attitudes and training were measured in reference to five MOUD types (methadone, oral buprenorphine, injectable buprenorphine, oral naltrexone, injectable naltrexone) on three subscales (effectiveness, acceptability, training).</p><p><strong>Results: </strong>Wilcoxon signed-rank tests demonstrated that most outcomes differed significantly by MOUD type (differences observed among 22 of 30 tests). Kruskal-Wallis tests suggested MOUD differences based on demographics. For methadone, CMHC providers endorsed greater perceived effectiveness than YLS providers and age explained significant differences in perceived effectiveness. For buprenorphine, CHMC providers viewed oral or injectable buprenorphine as more effective than YLS employees, respondents from more rural counties viewed oral buprenorphine as more effective than those from less rural counties, and age explained differences in perceived effectiveness. For naltrexone, perceived gender differed by gender. Hierarchical ordinal logistic regression analysis did not find an association between personal initiatives to implement EBPs, workplace culture supporting EBPs, or workplace stress and effectiveness or acceptability of MOUDs. However, personal initiatives to implement EBPs was associated with training in each MOUD.</p><p><strong>Conclusions: </strong>These results highlight a few key findings: effectiveness/acceptability of and training in MOUDs largely differ by MOUD type; setting, rurality, age, gender, and education explain group differences in perceived effectiveness of and training in MOUDs; and implementing EBPs is associated with training in MOUDs. Future research would benefit from examining what predicts change in MOUD attitudes longitudinally.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":"19 1","pages":"32"},"PeriodicalIF":3.0000,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11193280/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Substance Abuse Treatment, Prevention, and Policy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13011-024-00614-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Research demonstrates gaps in medications for opioid use disorder uptake (MOUDs; methadone, buprenorphine, and naltrexone) especially among adolescents. These gaps may be partly attributable to attitudes about and training in MOUDs among youth-serving professionals. We extended prior research by conducting descriptive analyses of attitudes regarding effectiveness and acceptability of MOUDs, as well as training in MOUDs, among youth legal system (YLS) employees and community mental health center (CMHC) personnel who interface professionally with youth.

Methods: Using survey data from participants (n = 181) recruited from eight Midwest counties, we examined: (1) differences in MOUD attitudes/training by MOUD type and (2) by respondent demographics, and (3) prediction of MOUD attitudes/training by participant-reported initiatives to implement evidence-based practices (EBPs), workplace culture around EBPs, and workplace stress. Attitudes and training were measured in reference to five MOUD types (methadone, oral buprenorphine, injectable buprenorphine, oral naltrexone, injectable naltrexone) on three subscales (effectiveness, acceptability, training).

Results: Wilcoxon signed-rank tests demonstrated that most outcomes differed significantly by MOUD type (differences observed among 22 of 30 tests). Kruskal-Wallis tests suggested MOUD differences based on demographics. For methadone, CMHC providers endorsed greater perceived effectiveness than YLS providers and age explained significant differences in perceived effectiveness. For buprenorphine, CHMC providers viewed oral or injectable buprenorphine as more effective than YLS employees, respondents from more rural counties viewed oral buprenorphine as more effective than those from less rural counties, and age explained differences in perceived effectiveness. For naltrexone, perceived gender differed by gender. Hierarchical ordinal logistic regression analysis did not find an association between personal initiatives to implement EBPs, workplace culture supporting EBPs, or workplace stress and effectiveness or acceptability of MOUDs. However, personal initiatives to implement EBPs was associated with training in each MOUD.

Conclusions: These results highlight a few key findings: effectiveness/acceptability of and training in MOUDs largely differ by MOUD type; setting, rurality, age, gender, and education explain group differences in perceived effectiveness of and training in MOUDs; and implementing EBPs is associated with training in MOUDs. Future research would benefit from examining what predicts change in MOUD attitudes longitudinally.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对阿片类药物使用障碍的态度和药物培训:对青少年法律系统和社区心理健康中心员工的描述性分析。
背景:研究表明,在阿片类药物使用障碍药物(MOUDs;美沙酮、丁丙诺啡和纳曲酮)的摄取方面存在差距,尤其是在青少年中。这些差距可能部分归因于青少年服务专业人员对 MOUDs 的态度和培训。我们扩展了之前的研究,对青少年法律系统(YLS)员工和社区心理健康中心(CMHC)中与青少年有专业接触的人员对MOUDs的有效性和可接受性的态度以及MOUDs培训进行了描述性分析:利用从美国中西部八个县招募的参与者(n = 181)的调查数据,我们研究了:(1)MOUD 类型和(2)受访者人口统计学在 MOUD 态度/培训方面的差异,以及(3)参与者报告的实施循证实践(EBPs)的举措、围绕 EBPs 的工作场所文化和工作场所压力对 MOUD 态度/培训的预测。对五种 MOUD 类型(美沙酮、口服丁丙诺啡、注射用丁丙诺啡、口服纳曲酮、注射用纳曲酮)的态度和培训进行了三个分量表(有效性、可接受性、培训)的测量:Wilcoxon 符号秩检验表明,大多数结果因 MOUD 类型的不同而有显著差异(30 项检验中有 22 项观察到差异)。Kruskal-Wallis 检验表明,基于人口统计学的 MOUD 存在差异。对于美沙酮,CMHC 提供者比 YLS 提供者更认可其感知效果,而年龄则解释了感知效果的显著差异。对于丁丙诺啡,CHMC 医疗服务提供者认为口服或注射丁丙诺啡比 YLS 员工更有效,来自较多农村县的受访者认为口服丁丙诺啡比来自较少农村县的受访者更有效,而年龄则解释了感知有效性的差异。就纳曲酮而言,不同性别的受访者对其有效性的认识存在差异。层次序数逻辑回归分析未发现实施 EBPs 的个人倡议、支持 EBPs 的工作场所文化或工作场所压力与 MOUDs 的有效性或可接受性之间存在关联。然而,个人实施 EBPs 的主动性与每个 MOUD 的培训有关:这些结果突出了几个重要发现:MOUD 的有效性/可接受性和培训在很大程度上因 MOUD 类型而异;环境、乡村、年龄、性别和教育程度解释了 MOUD 感知有效性和培训的群体差异;EBPs 的实施与 MOUD 培训有关。未来的研究将从纵向研究哪些因素可以预测慕课态度的变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.20
自引率
0.00%
发文量
73
审稿时长
19 weeks
期刊介绍: Substance Abuse Treatment, Prevention, and Policy is an open access, peer-reviewed journal that encompasses research concerning substance abuse, with a focus on policy issues. The journal aims to provide an environment for the exchange of ideas, new research, consensus papers, and critical reviews, to bridge the established fields that share a mutual goal of reducing the harms from substance use. These fields include: legislation pertaining to substance use; correctional supervision of people with substance use disorder; medical treatment and screening; mental health services; research; and evaluation of substance use disorder programs.
期刊最新文献
Enhancing the drug addiction treatment service by introducing a new residential treatment model in the Philippines: A qualitative study. COVID-19 public health restrictions and opioid overdoes: a summative content analysis of emergency medical services records in three Texas counties. The relationship between insecure attachment and nicotine dependence among users of classic cigarettes, e-cigarettes, and heated tobacco products: a moderated mediation model. Access and barriers to safer supply prescribing during a toxic drug emergency: a mixed methods study of implementation in British Columbia, Canada. Initiation and/or re-initiation of drug use among people who use drugs in Vancouver, Canada from 2021 to 2022: a prospective cohort study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1